Improving the Efficiency of Routine LC-MS/MS Assay with Multiplex UHPLC Platform
LC-MS/MS shows enormous capabilities for increasing sample throughput by monitoring multiple analytes simultaneously.
Featured
-
Breaking News | Collaborations & Alliances
CellPoint and Lonza Enter Strategic Collaboration
Will work together to deliver CAR-T Cell therapies to patients at point-of-care.06.24.21
-
Analytical Services | Laboratory Testing | R&D
-
Breaking News | Clinical Trial Materials
Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III
AGC Biologics will manufacture the clinical trial materials at its site in Copenhagen to support clinical testing and launch readiness.06.24.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Senti Bio Invests in Cell Therapy Manufacturing Facility
92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of allogeneic CAR-NK cell pipeline.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Frontera Therapeutics Starts GMP Manufacturing Facility Construction
Designed for clinical manufacturing and initial commercial manufacturing of rAAV gene therapy products.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News
AbCellera to Build Antibody Manufacturing Facility in Canada
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.06.23.21
-
Breaking News | Collaborations & Alliances
Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients
Cryoport will provide tracking and proactive management for the therapies.06.22.21
-
Breaking News | Industry News | Preclinical Outsourcing
Vectura, Incannex Enter Preclinical Services Agreement
Vectura to provide development services for IHL-216A, Incannex’s inhaled drug product for the treatment of traumatic brain injury.06.22.21
-
Breaking News | Clinical Trial Materials | Industry News
CaroGen, BioCentriq Enter Clinical Manufacturing Pact
BioCentriq to provide clinical manufacturing to support Phase 1 clinical trials of CaroGen's lead immunotherapy candidate, CARG-201.06.22.21
-
Breaking News | Packaging & Tracking
Schreiner MediPharm, Plas-Tech Partner on Prefilled Syringe Cap-Lock
Companies combine expertise on Cap-Lock tamper-evident security system for luer-lock syringes.06.22.21
-
Breaking News | Collaborations & Alliances
Iksuda, LegoChem Expand ADC Alliance
Grants Iksuda access to LegoChem's next generation ADC platform for up to six targets.06.22.21
-
Collaborations & Alliances | Drug Development
ProBioGen, LAVA to Develop Cell Lines for Bispecific Candidate
ProBioGen will conduct cell line development of a novel gamma-delta bsTCE using its CHO.RiGHT expression platform.06.22.21
-
Breaking News | Clinical Trials | CRO News
Syneos Expands Decentralized Trial Capabilities
Aims to accelerate decentralized clinical trial delivery through collaboration with site sponsors.06.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Danaher To Acquire Aldevron for $9.6B
Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.06.21.21
-
Breaking News | Facilities | Formulation Development | Industry News
Coriolis Pharma Expands ATMP Development Facilities
Construction of new facilities for ATMP formulation development up to biosafety level S2 are in progress and operations are expected to start by 4Q21.06.21.21
- AbCellera to Build Antibody Manufacturing Facility in Canada
- Maintaining Critical Drug Supply During the Pandemic
- Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
- BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
- AGC Biologics Inks Supply Deal for COVID-19 Vaccine
- Waking from the “Coma of COVID-19”
- Waving Goodbye to Human Clinical Trials in a Post-COVID Landscape
- Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine
- CPL Completes Successful Virtual Health Canada Audit
- Samsung Biologics Expands Vaccine Manufacturing Capabilities
- CellPoint and Lonza Enter Strategic Collaboration
- Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III
- Senti Bio Invests in Cell Therapy Manufacturing Facility
- Frontera Therapeutics Starts GMP Manufacturing Facility Construction
- AbCellera to Build Antibody Manufacturing Facility in Canada
- Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients
- Vectura, Incannex Enter Preclinical Services Agreement
- CaroGen, BioCentriq Enter Clinical Manufacturing Pact
- Schreiner MediPharm, Plas-Tech Partner on Prefilled Syringe Cap-Lock
- Iksuda, LegoChem Expand ADC Alliance
June 2021
- CRO Industry Update
- Preparing for Preclinical Testing: A Readiness Checklist
- Strategies for Entering Phase 1 Clinical Development with Limited API
- Meeting with the FDA: Valuing the Statistician and Preparation for Review
- CEO Spotlight: Patrick Haffey, Selkirk
- Biocatalysis: An Indispensable Tool for API Synthesis
- Addressing the Need for Standards in Cell and Gene Therapy
- Adapting Manufacturing for Super Small Batch, Precision Medicines
- 22nd Annual Salary Survey
- Newsmakers: Lynn Allen, Vice President of Business Development, MedPharm
Contract Service Directory
Search the Directories for A Company:
